Lobo Kevin 4

What Happened Kevin Lobo, a non-employee director of GE HealthCare Technologies Inc. (GEHC), was granted 777 restricted stock units (RSUs) on March 13, 2026. The RSUs were awarded at a $0.00 per-unit grant price (typical for equity awards) and represent the right to receive one share of GE HealthCare common stock per unit at settlement. This is an equity award (director compensation), not an open-market purchase or sale.

Key Details

• Transaction date and price: Grant on 2026-03-13; grant price $0.00 per RSU.
• Quantity: 777 RSUs (each equals one share at settlement).
• Vesting/settlement: 100% of the RSUs vest on the earlier of GE HealthCare’s next annual stockholder meeting or March 13, 2027. Settlement may be deferred per the director’s election under the company’s Non-Employee Director Compensation and Benefits Plan (see footnote).
• Shares owned after transaction: Not disclosed in the provided filing.
• Filing timeliness: Form 4 filed 2026-03-17 (appears to be within the SEC’s 2-business-day reporting window).
• Footnotes: F1 describes the vesting timing and possible deferral of settlement; F2 confirms each RSU converts to one share at settlement.

Context This is a standard director compensation award rather than a purchase or sale, so it generally reflects routine pay for board service rather than a directional bet on the stock. The economic value to the director depends on GE HealthCare’s share price at settlement and any deferral elections that may apply.